Extra- and intracellular signaling pathways under red blood cell aggregation and deformability changes

Clinical Hemorheology and Microcirculation

Volumn 43, Issue 3, 2009, Pages 223-232

  Muravyov, Alexei V ^a   Tikhomirova, Irina A ^a   Maimistova, Alla A ^a   Bulaeva, Svetlana V ^a  

^a Department of Medicine and Biology   (Russian Federation)

Author keywords

Adenylyl cyclase; Adrenergic receptors; Aggregation; Catecholamines; Forskolin; Intracellular signaling pathways; Phosphodiesterase; Red blood cell deformability

Indexed keywords

ADENYLATE CYCLASE; ANTITHROMBOCYTIC AGENT; CATECHOLAMINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; BLOOD; BLOOD RHEOLOGY; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HUMAN; MALE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADULT; CATECHOLAMINES; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HEMORHEOLOGY; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PLATELET AGGREGATION INHIBITORS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 76249129702     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2009-1212     Document Type: Article

References (46)

1. L. Berga, J. Dolz, J.L. Vives-Corrons, E. Feliu and C. Rozman, Viscometric methods for assessing red cell deformability and fragmentation, Biorheology 1(Suppl.) (1984), 297-301.
2. O. Linderkamp, G.B. Nash, P.Y. Wu and H.J. Meiselman, Deformability and intrinsic material properties of neonatal red blood cells, Blood 67 (1986), 1244-1250.
3. P. Bagchi, P.C. Johnson and A.S. Popel, Computational fluid dynamic stimulation of aggregation of deformable cells in a shear flow, J. Biomech. Eng. 127 (2005), 1070-1080.
4. S. de Oliveira, A.S. Silva-Herdade and C. Saldanha, Modulation of erythrocyte deformability by PKC activity, Clin. Hemorheol. Microcirc. 39 (2008), 363-373.
5. M.W. Ramping, The great divide: from viscometer to vasculature, Clin. Hemorheol. Microcirc. 39 (2008), 9-20.
6. M. Musielak, Red blood cell deformability measurement: Review of techniques, Clin. Hemorheol. Microcirc. 42 (2009), 47-64.
7. J.F. Stoltz, Red blood cell microrheology (clinical and pharmacological applications), Ric. Clin. Lab. 13(Suppl. 3) (1983), 53-70.
8. G.D. Lowe, Blood rheology in vitro and in vivo, Baillieres Clin. Haematol. 1 (1987), 597-636.
9. F. Jung, W. Erdlenbruch, H. Koscielny and H. Kiesewetter, Influence of hyper-/isovolaemic haemodilution with hydroxyethyl starch on blood fluidity, blood flow and tissue oxygen tension in patients with POAD stage II, Clin. Hemorheol.15(3) (1995), 415.
10. F. Jung, C. Mrowietz, D. Rickert, B. Hiebl, J.W. Park and R.P. Franke, The effect of radiographic contrast media on the morphology of human erythrocytes, Clin. Hemorheol. Microcirc. 38 (2008), 1-11.
11. D. Starzyk, R. Korbut and R.J. Gryglewski, Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro, J. Physiol. Pharmacol. 50(4) (1999), 629-637.
12. G. Késmárky, P. Kenyeres, M. Rábai and K. Tóth, Plasma viscosity: a forgotten variable, Clin. Hemorheol. Microcirc. 39 (2008), 243-246.
13. B.K. Lee, A. Durairaj, A. Mehra, R.B. Wenby, H.J. Meiselman and T. Alexy, Hemorheological abnormalities in stable angina and acute coronary syndromes, Clin. Hemorheol. Microcirc. 39 (2008), 43-51.
14. A. Vayá, J. Todolí, J. Calvo, M. Romagnoli and J.M. Ricart, Haemorheological profile in patients with systemic sclerosis, Clin. Hemorheol. Microcirc. 40 (2008), 243-248.
15. I. Velcheva, N. Antonova, E. Titianova, P. Damianov, N. Dimitrov and V. Dimitrova, Hemorheological disturbances in cerebrovascular diseases, Clin. Hemorheol. Microcirc. 39 (2008), 391-396.
16. M.M. Smith, P.C. Chen, C.S. Li, S. Ramanujam and A.T. Cheung, Whole blood viscosity and microvascular abnormalities in Alzheimer’s Disease, Clin. Hemorheol. Microcirc. 41 (2009), 229-239.
17. H. Schmid-Schönbein, Blood rheology and physiology of microcirculation, Ric. Clin. Lab. 11(Suppl. 1) (1981), 13-33.
18. O.K. Baskurt and H.J. Meiselman, Blood rheology and hemodynamics, Semin. Thromb. Hemost. 9 (2003), 435-450.
19. J. Stuart and G.B. Nash, Red cell deformability and haematological disorders, Blood Rev. 4(3) (1990), 141-147.
20. K. Matschke and F. Jung, Regulation of the myocardial microcirculation, Clin. Hemorheol.Microcirc. 39 (2008), 265-279.
21. S. Chien, Shear dependence of effective cell volume as a determinant of blood viscosity, Science 168 (1970), 977-978.
22. M. Cabel, H.J. Meiselman, A.S. Popel and P.C. Johnson, Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle, Am. J. Physiol. Heart Circ. Physiol. 272 (1997), H1020-H1032.
23. J.J. Bishop, P.R. Nance, A.S. Popel, M. Intaglietta and P.C. Johnson, Effect of erythrocyte aggregation on velocity profiles in venules, Am. J. Physiol. Heart Circ. Physiol. 280 (2001), H222-H236.
24. K. Oonishi, N. Sakashita and N. Uysaka, Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways, Am. J. Physiol. 273 (1997), C1828-C1834 (Cell. Physiol. 42).
25. S. Hilario, C. Saldanha and J. Martin-a-Silva, The effect of adrenaline upon human erythrocyte properties. Sex-related differences?, Biorheology 36(1/2) (1999), 124.
26. I.A. Tikhomiroiva, A.V. Muravyov and E.V. Kruglova, Hormonal control mechanisms of the rheological properties of erythrocytes under physical exercises and stress, Biorheology 45(1/2) (2008), Abstract, 49.
27. J. Sundquist, D.S. Bias, J.E. Hogan et al., The α1-adrenergic receptor in human erythrocyte membranes mediates interaction in vitro of epinephrine and thyroid hormone at the membrane Ca2+-ATPase, Cellular Signalling 4 (1992), 795-799.
28. G. Sager and S. Jacobsen, Effect of plasma on human erythrocyte beta-adrenergic receptors, Biochem. Pharmacol. 34 (1985), 3767-3771.
29. J.F. Horga, J. Gisbert, J.C. De Agustin et al., A beta-2-adrenergic receptor activates adenilate cyclase in human erythrocyte membranes at physiological calcium plasma concentrations, Blood Cell. Mol. Diseas. 26(3) (2000), 223-228.
30. S. Tuvia, A. Moses, N. Gulayev et al., Beta-adrenergic agonists regulate cellmembrane fluctuations of human erythrocytes, J. Physiol. 516 (1999), 781-787.
31. A.V. Muravyov, V.V. Yakusevich, A.A. Maimistova, F.A. Chuchkanov and S.V. Bulaeva, Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: In vitro study, Clin. Hemorheol. Microcirc. 24(1) (2007), 19-23.
32. G.M. Artmann, Microscopic photometric quantification of stiffness and relaxation time of red blood cells in a flow chamber, Biorheology 32(5) (1995), 553-570.
33. F. Bree, I. Gault, P. d’Athis and J.P. Tillement, Beta adrenoceptors of human red cells, determination of their subtypes, Biochem. Pharmacol. 33 (1984), 4045-4050.
34. S.A. Morris and J.P. Bilezikian, Evidence that forskolin activates turkey erythrocyte adenylate cyclase through a noncatalytic site, Arch. Biochem. Biophys. 220(2) (1983), 628-636.
35. J. Tepperman and H. Tepperman, Metabolic and Endocrine Physiology and Introductory Text, Year Book Publishers, Inc., Chicago-London, 1987.
36. S.G. Rosen, M.A. Berk, D.A. Popp, P. Serusclat et al., Beta 2- and alpha 2-adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiological variations of sex steroids, J. Clin. Endocrinol. Metab. 58 (1984), 1068-1076.
37. C. Wang, Y. Zeng and W. Ka, The influence of calcium ions and ionophore A23187 on microrheological characteristics of erythrocytes by new model ektacytometry, Clin. Hemorheol. Microcirc. 24(1) (2001), 19-23.
38. S.E. Adunyah and W.L. Dean, Regulation of human platelet membrane Ca2+ transport cAMP and calmodulin-dependent phosphorylation, Biochim. Biophys. Acta 930 (1987), 401-406.
39. G. Fuller and D. Shields, Molecular Basis of Medical Cell Biology, Appleton & Lange, Stamford, CT, 2000.
40. J.R. Creighton, N. Asada, D.M. Cooper and T. Steven, Coordinate regulation of membrane cAMP by Ca2+-inhibited adenylyl cyclase and phosphodiesterase activities, Am. J. Physiol. Lung Cell. Mol. Physiol. 284 (2003), L100-L107.
41. J.J. Olearczyk, A.H. Stephenson, A.J. Lonigro and R.S. Sprague, NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi, Am. J. Physiol. Heart Circ. Physiol. 287 (2004), H748-H754.
42. H. Rasmussen, W. Lake and J.E. Alien, The effect of catecholamines and prostaglandins upon human and rat erythrocytes, Biochim. Biophys. Acta 411 (1975), 63-73.
43. D.M. Cooper and G. Brooker, Ca2+-inhibited adenylate cyclase in cardiac tissue, Trends Pharmacol. Sci. 14 (1993), 34-35.
44. A.M. Ehrly, The effect of pentoxifylline on the flow properties of human blood, Curr. Med. Res. Opin. 5 (1978), 608-613.
45. G. Pindur, A. Sander, U.T. Seyfert and F. Jung, The effect of pentoxifylline on the deformability of erythrocytes in erythrocyte concentrates in additive solution, Anasthesiol. Intensivmed. Notfallmed. Schmerzth 36(Suppl. 1) (2001), S59-S61.
46. P.G. Phillips, Lu. Long, M.R. Wilkins and N.W. Morrell, cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling, Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005), L103-L115.